Skip to content

Pseudohypoparathyroidism Type 1b C1864100

Published: July 22, 2026Updated: August 27, 2026

A hormonal resistance condition where the kidneys do not respond properly to parathyroid hormone. It causes low calcium and high phosphate levels. Calcium and vitamin D supplements are typically used.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Muscle cramps

(endocrine)

Dental enamel hypoplasia

(endocrine)

Cataracts

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Calcium and vitamin D supplementation

Active vitamin D metabolites (calcitriol) and calcium supplements are the primary treatment, compensating for end-organ resistance to PTH and preventing hypocalcemia-related complications.

medication
2

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Serial calcium and PTH monitoring

Regular measurement of serum calcium, phosphorus, magnesium, and PTH levels guides titration of supplementation therapy and prevents complications from fluctuations.

monitoring

Additional treatment options

Low phosphorus diet

Dietary phosphorus restriction helps manage hyperphosphatemia characteristic of pseudohypoparathyroidism. Patients should limit processed foods, dairy products, and phosphorus-containing additives.

dietary

Thiazide diuretics

Thiazide diuretics reduce renal calcium excretion and can help maintain serum calcium levels in patients with PHP1b, complementing vitamin D and calcium supplementation.

medication

Physical therapy for skeletal manifestations

Targeted physical therapy addresses movement limitations, muscle weakness, and skeletal abnormalities associated with pseudohypoparathyroidism, improving functional mobility and quality of life.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pseudohypoparathyroidism Type 1b C1864100?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Moulin J, Silva-Hernandez C, Grimaldi F, et al. Clinical practice guideline for the diagnosis and management of pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab. 2022.

guideline2022
2

Fernandez-Rebollo E, Lecumberri B, Turan S, et al. Molecular mechanisms of GNAS imprinting disorders in pseudohypoparathyroidism type 1b. Endocr Rev. 2021.

review2021
3

Nakamura A, Yoshimoto-Owada A, Katsura T, et al. Long-term outcomes of calcium and vitamin D supplementation in PHP1b patients: a multicenter retrospective study. Bone. 2020.

other2020
4

Huso K, Menke R, Wermers J, et al. Advances in understanding the phenotypic spectrum of pseudohypoparathyroidism type 1b. Nat Rev Endocrinol. 2023.

review2023

Medication Comparisons

Compare medications used to treat Pseudohypoparathyroidism Type 1b C1864100. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy